Journal of Geriatric Oncology

Elsevier BV

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Journal of Geriatric Oncology is a journal published by Elsevier BV in United Kingdom. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 3,400 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier BV
ISSN
1879-4076 · 1879-4068
Country
United Kingdom
Access
Not open access / not declared
Declared publication charge
3,400 USD
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 2013-01-01
  • PUBMED · 2010-06-01
Indexing
MEDLINE · PUBMED
APC
3,400 USD
Declared review time (DOAJ)
—
Actual review time (measured)
130 days received→accepted — computed from PubMed (n=99)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

4095

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

73

i10-index

887

From OpenAlex open data (CC0).

Editorial & policy4
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
50%
ORCID iDs in current deposits
1%
Deposits licence metadata at Crossref
✓
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
101534770
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Frailty in Older Adults
  • Frailty in Older Adults
  • Cancer survivorship and care
  • Cancer survivorship and care
  • Nutrition and Health in Aging
  • Nutrition and Health in Aging
  • Palliative Care and End-of-Life Issues
  • Palliative Care and End-of-Life Issues
Show all subjects (50)
  • Health Systems, Economic Evaluations, Quality of Life
  • Health Systems, Economic Evaluations, Quality of Life
  • Cancer-related cognitive impairment studies
  • Cancer-related cognitive impairment studies
  • Economic and Financial Impacts of Cancer
  • Economic and Financial Impacts of Cancer
  • Cancer Treatment and Pharmacology
  • Cancer Treatment and Pharmacology
  • Colorectal Cancer Treatments and Studies
  • Colorectal Cancer Treatments and Studies
  • Breast Cancer Treatment Studies
  • Breast Cancer Treatment Studies
  • Global Cancer Incidence and Screening
  • Global Cancer Incidence and Screening
  • Advances in Oncology and Radiotherapy
  • Advances in Oncology and Radiotherapy
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Treatments and Mutations
  • Intensive Care Unit Cognitive Disorders
  • Intensive Care Unit Cognitive Disorders
  • Multiple and Secondary Primary Cancers
  • Colorectal Cancer Surgical Treatments
  • Colorectal Cancer Surgical Treatments
  • Multiple and Secondary Primary Cancers
  • Diverse Scientific and Economic Studies
  • Diverse Scientific and Economic Studies
  • Cardiac, Anesthesia and Surgical Outcomes
  • Cardiac, Anesthesia and Surgical Outcomes
  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers
  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Diagnosis and Treatment
  • Human auditory perception and evaluation
  • Human auditory perception and evaluation
  • Pharmaceutical Practices and Patient Outcomes
  • Acute Myeloid Leukemia Research
  • Acute Myeloid Leukemia Research
  • Pharmaceutical Practices and Patient Outcomes
  • Neutropenia and Cancer Infections
  • Neutropenia and Cancer Infections
  • Educational Robotics and Engineering
  • Educational Robotics and Engineering

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: